| For: | Wang LX, Wang GY, Su N, Ma J, Li YK. Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus. World J Clin Cases 2020; 8(18): 4010-4016 [PMID: 33024757 DOI: 10.12998/wjcc.v8.i18.4010] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i18/4010.htm |
| Number | Citing Articles |
| 1 |
Aravinda Jagadeesha, Vijay Viswanathan, Sanjay Agarwal, Anuj Maheshwari, Anil Kumar Virmani, Lakshmi Nagendra, Anoop Amarnath, Manoj Chawla, Pratap Jethwani, Rakesh Parikh, Sailatha Ravi. RSSDI guidelines for management of type 2 diabetes mellitus in older adults. International Journal of Diabetes in Developing Countries 2026; 46(1) doi: 10.1007/s13410-025-01613-8
|
| 2 |
Mohammadreza Heidari, Niloofar Mirdamadi, Pouria Khashayar, Ozra Tabatabaei-Malazy, Marzieh Golabchi, Patricia khashayar. Impact of metformin on bone turnover markers: a systematic review and meta-analysis of clinical trials. Archives of Osteoporosis 2026; 21(1) doi: 10.1007/s11657-026-01713-w
|
| 3 |
Mark F. McCarty, Lidianys Lewis Lujan, Simon Iloki Assanga. Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass. International Journal of Molecular Sciences 2022; 23(9) doi: 10.3390/ijms23094776
|
| 4 |
Xiaowei Yang, Qi Lai, Xinmin Yang, Banglin Xie, Bin Zhang, Xiaoyong Zhang, Yen Wei. Recent development and advances in the fabrication and biomedical applications of nanoparticle-based drug delivery systems for metformin. Materials Chemistry Frontiers 2022; 6(2) doi: 10.1039/D1QM01277K
|
| 5 |
Wei Mu, Guoqiang Liang, Yue Feng, Yunyun Jiang, Falin Qu. The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment. Pharmaceuticals 2022; 15(10) doi: 10.3390/ph15101274
|
| 6 |
Bo Wu, Zhaoyu Fu, Xinyu Wang, Pengcheng Zhou, Qifan Yang, Ye Jiang, Dong Zhu. A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1052592
|
| 7 |
Nicklas Højgaard-hessellund Rasmussen, Jakob Dal, Annika Vestergaard Kvist, Joop P. van den Bergh, Morten Hasselstrøm Jensen, Peter Vestergaard. Bone parameters in T1D and T2D assessed by DXA and HR-pQCT – A cross-sectional study: The DIAFALL study. Bone 2023; 172 doi: 10.1016/j.bone.2023.116753
|
| 8 |
Sashank Lekkala, Sara E Sacher, Erik A Taylor, Rebecca M Williams, Kendall F Moseley, Eve Donnelly. Increased Advanced Glycation Endproducts, Stiffness, and Hardness in Iliac Crest Bone From Postmenopausal Women With Type 2 Diabetes Mellitus on Insulin. Journal of Bone and Mineral Research 2020; 38(2) doi: 10.1002/jbmr.4757
|
| 9 |
Shakta Mani Satyam, Ebrahim Safaii, Ilmia Shameer, Rashmi Kumari, Sainath Prabhakar, Mohamed Talat Zaky Mahmoud Eltrabishi, Mohamed El-Tanani, Abdul Rehman, Mohamed Tarek Mohamed Wageh Mohamed Abdelfattah. Metformin as a Metabolic Reprogramming Interface in Host–Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss. Antibiotics 2026; 15(6) doi: 10.3390/antibiotics15060583
|
| 10 |
Hermine Carine Pouabe Epse Bodah, Suraiya Rahman Shifa, Sara Saleh, Tuba Abeer Hashmi, Tuleen Al Shawa, Badreshiya Kajal Akshaykumar, Nabeel Sufwan, Rajvinder Kaur, Andrii Shevchuk, Usman Ul Haq, Manju Rai. Bone Health in Type 1 and Type 2 Diabetes: Pathophysiological Mechanisms, Clinical Implications, and Management Strategies. SN Comprehensive Clinical Medicine 2025; 7(1) doi: 10.1007/s42399-025-02125-6
|
| 11 |
Tamás Tarjányi, Csaba Rosztóczy, Ferenc Peták, Fruzsina Kun-Szabó, Gábor Gulyás, József Tolnai, Krisztián Bali, Petra Somogyi, Rebeka Anna Kiss, Gergely H. Fodor. Nanomechanical Properties of Rib Bones in Diabetic vs. Healthy Rat Models. Nanomaterials 2025; 15(20) doi: 10.3390/nano15201582
|
| 12 |
Haiyan Zheng, Qian Wang, Min Si. Dapagliflozin combined with metformin improves blood glucose, bone metabolism and bone mineral density in elderly patients with type 2 diabetes mellitus complicated with osteoporosis. The Kaohsiung Journal of Medical Sciences 2025; 41(3) doi: 10.1002/kjm2.12937
|
| 13 |
Yining Wang, Liming Yu, Zhiqiang Ye, Rui Lin, Antonia RuJia Sun, Lingna Liu, Jinsong Wei, Feifu Deng, Xiangxin Zhong, Liao Cui, Li Li, Yanzhi Liu. Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1038603
|
| 14 |
Mingzhu Chen, Shuisen Lin, Wanqiong Chen, Xiaoqiang Chen, Carlos Alberto Antunes Viegas. Antidiabetic drug administration prevents bone mineral density loss: Evidence from a two-sample Mendelian randomization study. PLOS ONE 2024; 19(3) doi: 10.1371/journal.pone.0300009
|
| 15 |
Mohammed N. Abed, Fawaz A. Alassaf, Mohannad E. Qazzaz. Exploring the Interplay between Vitamin D, Insulin Resistance, Obesity and Skeletal Health. Journal of Bone Metabolism 2024; 31(2) doi: 10.11005/jbm.2024.31.2.75
|
| 16 |
Nikita Nirwan, Shreshta Jain, Divya Vohora. Linagliptin-metformin combination: A novel approach to mitigate 4-vinyl cyclohexene di epoxide and dexamethasone-induced osteoporosis in mice. Bone 2025; 198 doi: 10.1016/j.bone.2025.117526
|
| 17 |
Wenshu Xu, Ningning Jiang, Zhongyuan Zhang, Hui Xu. Exploring the role of metformin in high fluoride ingestion-induced bone lesions. Toxicology and Applied Pharmacology 2026; 506 doi: 10.1016/j.taap.2025.117653
|
| 18 |
Cheena Kumari, Ghozlan Yagoub, Mariam Ashfaque, Sobia Jawed, Pousette Hamid. Consequences of Diabetes Mellitus in Bone Health: Traditional Review. Cureus 2021; doi: 10.7759/cureus.13820
|
| 19 |
Pouria Khashayar, Farid Farahani Rad, Ozra Tabatabaei-Malazy, Sara MohammadHosseinzadeh Golabchi, Patricia Khashayar, Mehdi Mohammadi, Sholeh Ebrahimpour, Bagher Larijani. Hypoglycemic agents and bone health; an umbrella systematic review of the clinical trials’ meta-analysis studies. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01518-2
|
| 20 |
Yasmin Heydarzadeh Sohi, Ali Golestani, Ghodratollah Panahi, Ozra Tabatabaei-Malazy, Kazem Khalagi, Noushin Fahimfar, Afshin Ostovar, Mahnaz Sanjari, Bagher Larijani, Iraj Nabipour. The association between anti-diabetic agents and osteoporosis, sarcopenia, and osteosarcopenia among Iranian older adults; Bushehr Elderly Health (BEH) program. DARU Journal of Pharmaceutical Sciences 2023; 32(1) doi: 10.1007/s40199-023-00497-5
|
| 21 |
Faisal E. Aljofi, Aminah Alesawy, Bader Alzaben, Marwa Alshaikh, Norah Alotaibi, Hajer A. Aldulaijan, Sami Alshehri, Eman Aljoghaiman, Yousif A. Al-Dulaijan, Mishali AlSharief. Impact of Metformin on Periodontal and Peri-Implant Soft and Hard Tissue. International Journal of Environmental Research and Public Health 2023; 20(2) doi: 10.3390/ijerph20021095
|
| 22 |
Stavroula Psachna, Maria Eleni Chondrogianni, Konstantinos Stathopoulos, Antonis Polymeris, Antonios Chatzigeorgiou, Efstathios Chronopoulos, Symeon Tournis, Eva Kassi. The effect of antidiabetic drugs on bone metabolism: a concise review. Endocrine 2024; 87(3) doi: 10.1007/s12020-024-04070-1
|
| 23 |
Muthanna K. Zaki, Mohammed N. Abed, Fawaz A. Alassaf. Antidiabetic Agents and Bone Quality: A Focus on Glycation End Products and Incretin Pathway Modulations. Journal of Bone Metabolism 2024; 31(3) doi: 10.11005/jbm.2024.31.3.169
|
| 24 |
Lucrezia Irene Maria Campagnoli, Angelica Varesi, Foroogh Fahmideh, Reza Hakimizad, Petra Petkovic, Annalisa Barbieri, Nicoletta Marchesi, Alessia Pascale. From Diabetes to Degenerative Diseases: The Multifaceted Action of Metformin. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199748
|
| 25 |
Abdul Rahaman Shaik, Sunil Kohli, Divya Vohora. Bone effects of metformin monotherapy and its combination with teneligliptin: A 12-week follow-up study in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2024; 213 doi: 10.1016/j.diabres.2024.111744
|